MidAmerica Neuroscience Institute is a clinical research site located in Lenexa, Kansas, United States 66214.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
MidAmerica Neuroscience Institute has participated in 10 clinical trials.
Therapeutic areas: Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome, Spasticity.
Sponsors: Opexa Therapeutics, Inc., Impax Laboratories, LLC, JANSSEN Alzheimer Immunotherapy Research & Development, LLC.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
MidAmerica Neuroscience Institute has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MidAmerica Neuroscience Institute has 10 clinical trials on record. Their work covers Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome, Spasticity.
Yes — MidAmerica Neuroscience Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.